Amy Jenkins

Dr. Amy Jenkins is currently the Senior Director of Strategy and Operations within the Vaccines and Immune Therapies Unit at AstraZeneca. Prior to joining AstraZeneca, Dr. Jenkins was the Acting Deputy Director of the Advanced Research Projects Agency for Health (ARPA-H) assisting in the management of the agency from a strategic planning and scientific perspective. She served as the inaugural director of the Health Science Futures Office within ARPA-H where she managed a diverse office focused on revolutionary technology innovations in osteoarthritis, cancer, cell and gene therapy, vaccinology, manufacturing, and neuroscience. 

She also served as a program manager in the Biological Technologies Office at DARPA. Her portfolio included programs aimed at the development of platforms for combatting infectious disease threats using nucleic acid vectored monoclonal antibodies and novel synthetic biology tools. She had a particular focus within her portfolio on novel manufacturing methods to enable rapid response. She has served as a Project Coordination Team lead for Operation Warp Speed, driving the development of monoclonal antibodies for the treatment and prevention of covid-19 disease.

She received her Doctor of Philosophy degree in Chemistry and Chemical Biology from Cornell University and her Bachelor of Science in Chemistry and Biomolecular Science from Clarkson University.